ACR Acrux Limited
—Mkt Cap: —P/E: —1d ago
Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally. The company offers Dapsone 7.5% and 5% ge…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value5.04M USD
Revenue (TTM)4.55M USD
Gross Profit2.97M USD
Net Income (TTM)-417.41K USD
Revenue/Share0.02 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000ACR3
Valuation
P/E (Trailing)—
P/E (Forward)-0.28
PEG0.42
EV/EBITDA-429.38
EV/Revenue1.11
P/S1.02
P/B3.67
EPS (TTM)0.00
EPS (Forward)-0.04
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin32.60%
EBITDA Margin-0.26%
Profit Margin-14.05%
ROE-41.17%
ROA-10.35%
Growth
Revenue Growth10.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF704.21K USD
CapEx (TTM)—
FCF Margin17.21%
FCF Yield—
Net Debt561.85K USD
Net Debt/EBITDA-47.82
Balance Sheet
Debt/Equity1.72
Current Ratio1.37
Quick Ratio1.36
Book Value/Sh0.0030 AUD
Cash/Share0.0030 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield4.58%
Payout Ratio0.00%
Ex-Div DateAug 18, 2015
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.611.65M
Float398.69M
Insiders23.17%
Institutions7.02%
Technical
SMA 500.0103 AUD
SMA 2000.0120 AUD
Beta1.02
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)1.35M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—